Shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA) Rise as it Adds Amy Yoder to its Board Of Directors

Shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA) Rise as it Adds Amy Yoder to its Board Of Directors

Agricultural technology company, Arcadia Biosciences, Inc. (NASDAQ:RKDA), has announced that Amy Yoder is joining its board of directors. Arcadia Biosciences, Inc. (RKDA), an agricultural technology company that creates value for farmers while benefitting the environment and enhancing human health, announced today that Amy Yoder has joined its board of directors. Yoder is president and CEO of Anuvia Plant Nutrients, a company that creates enhanced plant nutrition products from recycled organic […]

Read More ˃
Argos Therapeutics, Inc. (NASDAQ:ARGS) Reports Q2 2017 Financial Results as Share Price Jumps

Argos Therapeutics, Inc. (NASDAQ:ARGS) Reports Q2 2017 Financial Results as Share Price Jumps

Immuno-oncology company focused on the development and commercialization of individualized immunotherapies, Argos Therapeutics, Inc. (NASDAQ:ARGS), has reported financial results for Q2, 2017. DURHAM, N.C., Aug. 09, 2017 (GLOBE NEWSWIRE) — Argos Therapeutics Inc. (ARGS), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the ArcelisĀ® precision immunotherapy technology platform, today reported financial results for the second quarter ended June 30, 2017 and provided an update […]

Read More ˃
Shares of RXi Pharmaceuticals, Corp. (NASDAQ:RXII) Up After Entering into $15 Million Common Stock Purchase Agreement

Shares of RXi Pharmaceuticals, Corp. (NASDAQ:RXII) Up After Entering into $15 Million Common Stock Purchase Agreement

Clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, RXi Pharmaceuticals, Corp. (NASDAQ:RXII), announce a purchase agreement of common stock with Lincoln Park Capital Fund. MARLBOROUGH, Mass., Aug. 9, 2017 /PRNewswire/ — RXi Pharmaceuticals Corporation (RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, today announced that it has entered into a common stock purchase agreement with Lincoln Park Capital Fund, LLC […]

Read More ˃